Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
DEAR DR. ROACH: A few months ago, you wrote about the benefits of the shingles vaccine. At 63, I’m one of the 1% who has ...
Amid warnings of a 'tripledemic' of cold, flu and Covid this winter, millions could bypass the GP queue and directly access ...
There are often lengthy waits to get an appointment with a doctor but if you have one of these conditions you can dodge the ...
Amid warnings of a 'tripledemic' of cold, flu and Covid this winter, millions could bypass the GP queue and directly access ...